Sitagliptin Phosphate Tablets are antihyperglycemic medications that work primarily with dietary control and exercise to improve glycemic control in patients with type 2 diabetes.This medication can also be used in combination with metformin hydrochloride or insulin. Sitagliptin phosphate tablets are a DPP-4 inhibitor that can improve glycemic control by increasing levels of active enteric insulinotropic hormone in patients with type 2 diabetes. Adverse reactions to selegiline phosphate tablets include symptoms of hypoglycemia, diarrhea, abdominal pain, nausea, headache, nasopharyngitis, hypersensitivity reactions, hyperalgesia, and upper respiratory tract infections. It is important to note that selegiline phosphate tablets are contraindicated in patients who are allergic to the components of the drug, are contraindicated in patients with diabetes mellitus type 1 or diabetic ketoacidosis, and are contraindicated in pregnant women and lactating mothers, and the safety and efficacy of the drug for children under 18 years of age has not been established. If you need to use selegiline phosphate tablets, it is recommended to consult a professional doctor and follow the doctor’s instructions to standardize the use of medication.